These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25239121)

  • 1. Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma.
    Qin C; Chen J; Li J; Ju X; Zhang S; Cao Q; Han Z; Li P; Shao P; Wang M; Zhang Z; Gu M; Zhang W; Yin C
    Mutagenesis; 2014 Nov; 29(6):419-25. PubMed ID: 25239121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of polymorphisms in angiogenesis-related genes as predictive and prognostic markers for sunitinib-treated metastatic renal cell carcinoma patients.
    Dornbusch J; Walter M; Gottschalk A; Obaje A; Junker K; Ohlmann CH; Meinhardt M; Zacharis A; Zastrow S; Schoffer O; Grimm MO; Klug SJ; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1171-82. PubMed ID: 26935927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
    Safarinejad MR; Shafiei N; Safarinejad S
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
    Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure.
    Ravegnini G; Nannini M; Zenesini C; Simeon V; Sammarini G; Urbini M; Gatto L; Saponara M; Biasco G; Pantaleo MA; Venturoli N; Hrelia P; Angelini S
    Angiogenesis; 2017 Feb; 20(1):139-148. PubMed ID: 27896475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma.
    Beuselinck B; Verbiest A; Couchy G; Job S; de Reynies A; Meiller C; Albersen M; Verkarre V; Lerut E; Méjean A; Patard JJ; Laguerre B; Rioux-Leclercq N; Schöffski P; Oudard S; Zucman-Rossi J
    Acta Oncol; 2018 Apr; 57(4):498-508. PubMed ID: 29095068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma.
    Joseph RW; Parasramka M; Eckel-Passow JE; Serie D; Wu K; Jiang L; Kalari K; Thompson RH; Huu Ho T; Castle EP; Cheville J; Kwon ED; Thompson EA; Parker A
    Cancer Immunol Res; 2013 Dec; 1(6):378-85. PubMed ID: 24778130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
    Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
    Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Genetic Polymorphisms in the
    Luo Y; Luo J; Peng H
    Genet Test Mol Biomarkers; 2019 Sep; 23(9):644-651. PubMed ID: 31524543
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility.
    Zhang GM; Wang MY; Liu YN; Zhu Y; Wan FN; Wei QY; Ye DW
    Carcinogenesis; 2017 Dec; 38(12):1241-1248. PubMed ID: 29029037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.
    Safarinejad MR
    BJU Int; 2011 Sep; 108(5):762-70. PubMed ID: 21314884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between Vascular Endothelial Growth Factor-A (rs2010963) Gene Polymorphisms and Dietary Diversity Score on Cardiovascular Risk Factors in Patients with Metabolic Syndrome.
    Abbasalizad Farhangi M; Vajdi M; Nikniaz L; Nikniaz Z
    Lifestyle Genom; 2020; 13(1):1-10. PubMed ID: 31786572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
    Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
    Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory SNPs Alter the Gene Expression of Diabetic Retinopathy Associated Secretary Factors.
    Chen CF; Liou SW; Wu HH; Lin CH; Huang LS; Woung LC; Tsai CY
    Int J Med Sci; 2016; 13(9):717-23. PubMed ID: 27648002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis.
    Hou Q; Li MY; Huang WT; Wei FF; Peng JP; Lou MW; Qiu JG
    Oncotarget; 2017 Jul; 8(30):50061-50070. PubMed ID: 28562357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free RNA content in urine as a possible molecular diagnostic tool for clear cell renal cell carcinoma.
    Zhao A; Péoc'h M; Cottier M; Genin C; Mottet N; Li G
    Int J Cancer; 2015 Jun; 136(11):2610-5. PubMed ID: 25379634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
    Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
    Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of angiogenesis-related miRNAs in a population of patients with renal clear cell carcinoma.
    Li HC; Li JP; Wang ZM; Fu DL; Li ZL; Zhang D; Gan WM; Chong T
    Oncol Rep; 2014 Nov; 32(5):2061-9. PubMed ID: 25119741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.
    Edeline J; Mottier S; Vigneau C; Jouan F; Perrin C; Zerrouki S; Fergelot P; Patard JJ; Rioux-Leclercq N
    Hum Pathol; 2012 Nov; 43(11):1982-90. PubMed ID: 22626276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P; Ye L; Yang Y; Jiang WG
    Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.